Commentary: Biden shouldn’t disarm pharmaceutical innovation that’s winning war on Covid
Commentary: Doug Badger, The Heritage Foundation
By Doug Badger, The Heritage Foundation, (TNS)
As the Covid-19 vaccines show, pharmaceutical innovation provides the best hope of ending the pandemic. Unfortunately, the Biden administration is launching what amounts to a federal assault against such innovation.
That assault will take the form of federal price controls on prescription medicines. When the House of Representatives attempted to impose such controls in 2019, the White House Council of Economic Advisers said it could result in as many as 100 fewer drugs entering the market over the next decade.